ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Anti-hyperuricemia activity and toxicity prediction of a novel xanthine oxidoreductase inhibitor

Zhou, Liping; Wei, Baxiong; Wu, Lvying; Li, Jing; Zhu, Bin*; Zhang, Lei*
Biomedical Chromatography2020-2DOI: 10.1002/bmc.4727
2被引7阅读
引用收藏
分享

摘要

A potent xanthine oxidoreductase inhibitor (LS087) was recently proved to exhibit a similar hypouricemic potency to febuxostat. A hyperuricemia model induced by potassium oxonate and hypoxanthine was proposed in specific pathogen-free male Kunming mice, and the serum urea nitrogen, creatinine and uric acid levels were measured after oral administration of LS087. Furthermore, renal histopathology was conducted by staining with hematoxylin and eosin, periodic acid-Schiff and Masson's trichrome stains, respectively. The results showed that the levels of serum urea nitrogen and uric acid significantly decreased compared with the model group, but the level of creatinine showed no significant changes. The pathological abnormalities in kidney tubules were improved after LS087 administration. Ten metabolites (M1-M10) of LS087 were identified after a single oral dosing of 10 mg/kg in rats. M6 was the primary LS087 metabolite in vivo with a pathway of methylation. The toxicity and potential risks of LS087 and its metabolites were predicted using the ProTox-II software. LS087 and the major metabolites (M2, M3, M5, M6, M7 and M8) were predicted to have no potential hepatotoxicity, but some metabolites with a total rate of <1% (M1, M4, M9, and M10) showed potential hepatotoxicity. M1 and M8 showed potential carcinogenicity. The LS087 biotransformation pathway in rat was well characterized.

学科与关键词

关键词
xanthine oxidoreductaseinhibitormetaboliteserum biochemical assayrenal histopathology
相关
加载中…
  • Synthesis and bioevaluation of 1-phenylimidazole-4-carboxylic acid derivatives as novel xanthine oxidoreductase inhibitors
    Zhou, Haiyan; Li, Xiaolei; Li, Yuanyuan; Zhu, Xinying; Zhang, Lei; Li, Jing*European Journal of Medicinal Chemistry, 2020, 186: 111883.被引 7
  • A modified xanthine oxidase cell model for screening of antihyperuricemic functional compounds
    Hou, Chuanli; Sha, Wangqian; Li, Yujuan; Yao, Maojin; Ren, Jiaoyan*Food & Function, 2022, 13(20): 10546-10557.被引 2
  • Eupatilin inhibits xanthine oxidase in vitro and attenuates hyperuricemia and renal injury in vivo
    Xu, Guitao; Wu, Lele; Yang, Hongxuan; Liu, Tianfeng; Tong, Ying; Wan, Jiliang; Han, Bin; Zhou, Lin*; Hu, Xuguang*Food and Chemical Toxicology, 2024, 183: 114307.
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomedical Chromatography
发表日期
2020-02
卷期
第 34 卷, 第 2 期
页码
e4727
DOI
10.1002/bmc.4727
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
4区
成果收录
SCIE
资助标注
Guangdong Provincial Department of Science and Technology [2016A010121004, 2016B090918075]

作者

  • Z

    Zhou, Liping (第一作者)

  • W

    Wei, Baxiong

查看全部 6 位作者收起作者
  • W

    Wu, Lvying

  • L

    Li, Jing

  • Z

    Zhu, Bin (通讯)

  • Z

    Zhang, Lei (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417